nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—myometrium—uterine cancer	0.0226	0.125	CbGeAlD
Gadopentetate dimeglumine—PGD—uterine cervix—uterine cancer	0.0176	0.097	CbGeAlD
Gadopentetate dimeglumine—PGD—smooth muscle tissue—uterine cancer	0.0171	0.0943	CbGeAlD
Gadopentetate dimeglumine—PGD—decidua—uterine cancer	0.0168	0.0925	CbGeAlD
Gadopentetate dimeglumine—PGD—renal system—uterine cancer	0.0165	0.0908	CbGeAlD
Gadopentetate dimeglumine—PGD—endometrium—uterine cancer	0.0159	0.0878	CbGeAlD
Gadopentetate dimeglumine—PGD—mammalian vulva—uterine cancer	0.0154	0.0849	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—uterine cancer	0.0147	0.0809	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—uterine cancer	0.0132	0.0727	CbGeAlD
Gadopentetate dimeglumine—PGD—female gonad—uterine cancer	0.012	0.0662	CbGeAlD
Gadopentetate dimeglumine—PGD—vagina—uterine cancer	0.0119	0.0658	CbGeAlD
Gadopentetate dimeglumine—PGD—lymph node—uterine cancer	0.00771	0.0425	CbGeAlD
Gadopentetate dimeglumine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Pulmonary oedema—Doxorubicin—uterine cancer	0.0012	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Progesterone—uterine cancer	0.00119	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Etoposide—uterine cancer	0.00118	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Etoposide—uterine cancer	0.00118	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Etoposide—uterine cancer	0.00117	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Eye pain—Epirubicin—uterine cancer	0.00117	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Chills—Etoposide—uterine cancer	0.00117	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00116	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Progesterone—uterine cancer	0.00115	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Renal failure acute—Epirubicin—uterine cancer	0.00114	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Rash—Progesterone—uterine cancer	0.00114	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Progesterone—uterine cancer	0.00114	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Doxorubicin—uterine cancer	0.00113	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Headache—Progesterone—uterine cancer	0.00113	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00113	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Dactinomycin—uterine cancer	0.00111	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Etoposide—uterine cancer	0.00111	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Epirubicin—uterine cancer	0.00111	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Dactinomycin—uterine cancer	0.0011	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Etoposide—uterine cancer	0.0011	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Pain—Dactinomycin—uterine cancer	0.00109	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00109	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Eye pain—Doxorubicin—uterine cancer	0.00108	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Progesterone—uterine cancer	0.00107	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Renal failure acute—Doxorubicin—uterine cancer	0.00106	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Epirubicin—uterine cancer	0.00105	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Epirubicin—uterine cancer	0.00105	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Dactinomycin—uterine cancer	0.00105	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00104	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Epirubicin—uterine cancer	0.00104	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Doxorubicin—uterine cancer	0.00102	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Etoposide—uterine cancer	0.00102	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Epirubicin—uterine cancer	0.00102	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Dactinomycin—uterine cancer	0.00101	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Dactinomycin—uterine cancer	0.00101	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00101	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Epirubicin—uterine cancer	0.001	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Etoposide—uterine cancer	0.000995	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Cough—Etoposide—uterine cancer	0.000988	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Epirubicin—uterine cancer	0.000988	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Etoposide—uterine cancer	0.000981	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Etoposide—uterine cancer	0.000978	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Doxorubicin—uterine cancer	0.000975	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Doxorubicin—uterine cancer	0.000975	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000973	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Etoposide—uterine cancer	0.000964	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Epirubicin—uterine cancer	0.000963	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Doxorubicin—uterine cancer	0.00096	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000958	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000949	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Epirubicin—uterine cancer	0.000943	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—uterine cancer	0.000942	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Dactinomycin—uterine cancer	0.000941	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Etoposide—uterine cancer	0.000932	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—uterine cancer	0.000927	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Etoposide—uterine cancer	0.000924	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dactinomycin—uterine cancer	0.000916	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000914	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Etoposide—uterine cancer	0.000902	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Etoposide—uterine cancer	0.000898	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Etoposide—uterine cancer	0.000894	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000891	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Epirubicin—uterine cancer	0.000887	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Etoposide—uterine cancer	0.000881	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000878	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dactinomycin—uterine cancer	0.000874	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000872	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Etoposide—uterine cancer	0.000864	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Epirubicin—uterine cancer	0.000842	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Etoposide—uterine cancer	0.00083	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Etoposide—uterine cancer	0.000824	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Etoposide—uterine cancer	0.000822	0.001	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—uterine cancer	0.000821	0.001	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Epirubicin—uterine cancer	0.000812	0.000992	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dactinomycin—uterine cancer	0.000812	0.000992	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dactinomycin—uterine cancer	0.000805	0.000984	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Etoposide—uterine cancer	0.000803	0.000981	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Epirubicin—uterine cancer	0.000799	0.000975	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000798	0.000975	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Etoposide—uterine cancer	0.000797	0.000973	CcSEcCtD
Gadopentetate dimeglumine—Pain—Etoposide—uterine cancer	0.00079	0.000965	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Etoposide—uterine cancer	0.00079	0.000965	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Epirubicin—uterine cancer	0.00079	0.000965	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Epirubicin—uterine cancer	0.000779	0.000951	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—uterine cancer	0.000779	0.000951	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000768	0.000938	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Etoposide—uterine cancer	0.000762	0.00093	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dactinomycin—uterine cancer	0.000759	0.000927	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Etoposide—uterine cancer	0.000756	0.000923	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—uterine cancer	0.000752	0.000918	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—uterine cancer	0.000742	0.000907	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—uterine cancer	0.000739	0.000903	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Etoposide—uterine cancer	0.000734	0.000897	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—uterine cancer	0.000731	0.000893	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Etoposide—uterine cancer	0.000731	0.000893	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Etoposide—uterine cancer	0.000731	0.000893	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—uterine cancer	0.000731	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—uterine cancer	0.000721	0.00088	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—uterine cancer	0.00072	0.00088	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—uterine cancer	0.000718	0.000878	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—uterine cancer	0.000717	0.000875	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—uterine cancer	0.000715	0.000873	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000711	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—uterine cancer	0.000703	0.000858	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—uterine cancer	0.00069	0.000842	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—uterine cancer	0.000687	0.000839	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—uterine cancer	0.000682	0.000832	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Etoposide—uterine cancer	0.000681	0.000832	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—uterine cancer	0.00068	0.000831	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—uterine cancer	0.000677	0.000827	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—uterine cancer	0.000677	0.000827	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—uterine cancer	0.000676	0.000826	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000666	0.000814	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—uterine cancer	0.000665	0.000812	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Etoposide—uterine cancer	0.000663	0.00081	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000663	0.00081	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—uterine cancer	0.000662	0.000808	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—uterine cancer	0.000661	0.000808	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—uterine cancer	0.000659	0.000805	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—uterine cancer	0.000657	0.000803	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—uterine cancer	0.000654	0.000799	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Etoposide—uterine cancer	0.000654	0.000799	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—uterine cancer	0.000651	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—uterine cancer	0.00065	0.000794	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—uterine cancer	0.000639	0.00078	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—uterine cancer	0.000638	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—uterine cancer	0.000635	0.000775	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Etoposide—uterine cancer	0.000632	0.000772	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—uterine cancer	0.000631	0.00077	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—uterine cancer	0.000629	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—uterine cancer	0.000626	0.000765	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—uterine cancer	0.000626	0.000765	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—uterine cancer	0.000623	0.000761	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—uterine cancer	0.000622	0.000759	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—uterine cancer	0.000614	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—uterine cancer	0.000612	0.000748	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Etoposide—uterine cancer	0.000611	0.000747	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—uterine cancer	0.000609	0.000744	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000608	0.000743	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—uterine cancer	0.000605	0.00074	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—uterine cancer	0.000603	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—uterine cancer	0.000591	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Etoposide—uterine cancer	0.000588	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—uterine cancer	0.000587	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—uterine cancer	0.000583	0.000713	CcSEcCtD
Gadopentetate dimeglumine—Rash—Etoposide—uterine cancer	0.000583	0.000712	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Etoposide—uterine cancer	0.000582	0.000711	CcSEcCtD
Gadopentetate dimeglumine—Headache—Etoposide—uterine cancer	0.000579	0.000707	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—uterine cancer	0.000576	0.000704	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—uterine cancer	0.000575	0.000703	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—uterine cancer	0.000572	0.000699	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—uterine cancer	0.000569	0.000695	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—uterine cancer	0.000568	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—uterine cancer	0.000558	0.000682	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—uterine cancer	0.000554	0.000677	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—uterine cancer	0.00055	0.000672	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Etoposide—uterine cancer	0.000549	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—uterine cancer	0.000548	0.000669	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—uterine cancer	0.00054	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—uterine cancer	0.00054	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—uterine cancer	0.00054	0.000659	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—uterine cancer	0.000539	0.000658	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000537	0.000656	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—uterine cancer	0.00053	0.000647	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—uterine cancer	0.000529	0.000646	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—uterine cancer	0.000527	0.000643	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—uterine cancer	0.000522	0.000638	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—uterine cancer	0.000518	0.000633	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—uterine cancer	0.000516	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—uterine cancer	0.000513	0.000626	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—uterine cancer	0.00051	0.000623	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—uterine cancer	0.000509	0.000622	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—uterine cancer	0.000508	0.000621	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—uterine cancer	0.000507	0.000619	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—uterine cancer	0.000506	0.000618	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—uterine cancer	0.000503	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—uterine cancer	0.000501	0.000612	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—uterine cancer	0.0005	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—uterine cancer	0.0005	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—uterine cancer	0.000498	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000497	0.000607	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—uterine cancer	0.000494	0.000603	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—uterine cancer	0.000489	0.000597	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—uterine cancer	0.000484	0.000591	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—uterine cancer	0.000483	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000479	0.000586	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000472	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—uterine cancer	0.000472	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—uterine cancer	0.00047	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—uterine cancer	0.000468	0.000572	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—uterine cancer	0.000466	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—uterine cancer	0.000465	0.000568	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000463	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—uterine cancer	0.000462	0.000564	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—uterine cancer	0.000461	0.000563	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—uterine cancer	0.000457	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—uterine cancer	0.00045	0.00055	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—uterine cancer	0.000448	0.000547	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000447	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—uterine cancer	0.000447	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—uterine cancer	0.000443	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—uterine cancer	0.000443	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000437	0.000534	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—uterine cancer	0.00043	0.000526	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—uterine cancer	0.000427	0.000522	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—uterine cancer	0.000427	0.000522	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—uterine cancer	0.000426	0.000521	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000424	0.000518	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—uterine cancer	0.000417	0.000509	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000414	0.000506	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—uterine cancer	0.000413	0.000505	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—uterine cancer	0.000412	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—uterine cancer	0.00041	0.000501	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—uterine cancer	0.00041	0.000501	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—uterine cancer	0.00041	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—uterine cancer	0.00041	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—uterine cancer	0.000395	0.000483	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000392	0.000479	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—uterine cancer	0.000382	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—uterine cancer	0.000381	0.000465	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—uterine cancer	0.000379	0.000463	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—uterine cancer	0.000379	0.000463	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—uterine cancer	0.000372	0.000454	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—uterine cancer	0.000367	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—uterine cancer	0.000354	0.000433	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—uterine cancer	0.000353	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—uterine cancer	0.000344	0.00042	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—uterine cancer	0.000343	0.000419	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—uterine cancer	0.000339	0.000414	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—uterine cancer	0.000329	0.000402	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—uterine cancer	0.000328	0.000401	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—uterine cancer	0.000327	0.000399	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—uterine cancer	0.000326	0.000399	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—uterine cancer	0.000325	0.000396	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—uterine cancer	0.000317	0.000387	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—uterine cancer	0.000308	0.000376	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—uterine cancer	0.000305	0.000372	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—uterine cancer	0.000302	0.000369	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—uterine cancer	0.000302	0.000369	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—uterine cancer	0.0003	0.000367	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—uterine cancer	0.000285	0.000348	CcSEcCtD
